Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression

被引:39
作者
Bacher, U [1 ]
Haferlach, T [1 ]
Hiddemann, W [1 ]
Schnittger, S [1 ]
Kern, W [1 ]
Schoch, C [1 ]
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Internal Med 3, Lab Leukemia Diagnost, D-81377 Munich, Germany
关键词
D O I
10.1016/j.cancergencyto.2004.06.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The cytogenetic patterns in addition to the Philadelphia translocation in Philadelphia-positive (Ph+) ALL and chronic myeloid leukemia (CML) is heterogenous. We investigated 154 patients with Ph+ ALL at diagnosis or at relapse and 174 patients with different phases of CNIL. Ph+ ALL at diagnosis demonstrated a heterogenous pattern with a high frequency of numerical and structural chromosomal aberrations. CML at diagnosis presented with rare additional chromosomal changes. In Ph+ ALL, the pathway from diagnosis to relapse was characterized by the acquisition of a higher number of chromosomal aberrations, but the pattern of frequent aberrations at relapse did not differ from that observed at diagnosis. In contrast, in CNIL the pathway from chronic to the advanced phases was characterized by the acquisition of new chromosomal changes and by the development of karyotype complexity. In addition, the investigation of 10 cases of lymphoid blast crisis of CML showed significant differences in the karyotype in comparison to Ph+ ALL at diagnosis. Therefore, the karyotype can be helpful in discriminate de novo lymphoid blast crisis of CML from de novo Ph+ ALL. In conclusion, we were able to demonstrate that the cytogenetic patterns of Ph+ ALL and of CML are different at diagnosis and furthermore follow different pathways during progression or relapse. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 26 条
[1]
Charrin C, 1996, BLOOD, V88, P2818
[2]
CRIST W, 1990, BLOOD, V76, P489
[3]
MINOR MYELOID COMPONENT IN PH CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA - CORRELATION WITH CYTOGENETIC PATTERN AND IMPLICATION FOR POOR RESPONSE TO THERAPY [J].
CUNEO, A ;
DEMUYNCK, H ;
FERRANT, A ;
LOUWAGIE, A ;
DOYEN, C ;
STUL, M ;
CASSIMAN, JJ ;
DALCIN, P ;
NEGRINI, M ;
CARLI, MG ;
BOOGAERTS, M ;
MICHAUX, JL ;
CASTOLDI, G ;
VANDENBERGHE, H .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (03) :515-522
[4]
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia -: results of the prospective multicenter LALA-94 trial [J].
Dombret, H ;
Gabert, J ;
Boiron, JM ;
Rigal-Huguet, F ;
Blaise, D ;
Thomas, X ;
Delannoy, A ;
Buzyn, A ;
Bilhou-Nabera, C ;
Cayuela, JM ;
Fenaux, P ;
Bourhis, JH ;
Fegueux, N ;
Charrin, C ;
Boucheix, C ;
Lhéritier, V ;
Espérou, H ;
MacIntyre, E ;
Vernant, JP ;
Fière, D .
BLOOD, 2002, 100 (07) :2357-2366
[5]
Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia [J].
Faderl, S ;
Kantarjian, HM ;
Talpaz, M ;
Estrov, Z .
BLOOD, 1998, 91 (11) :3995-4019
[6]
Faderl S, 1999, ONCOLOGY-NY, V13, P169
[7]
Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia:: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis [J].
Gleissner, B ;
Gökbuget, N ;
Bartram, CR ;
Janssen, B ;
Rieder, H ;
Janssen, JWG ;
Fonatsch, C ;
Heyll, A ;
Voliotis, D ;
Beck, J ;
Lipp, T ;
Munzert, G ;
Maurer, J ;
Hoelzer, D ;
Thiel, E .
BLOOD, 2002, 99 (05) :1536-1543
[8]
Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment [J].
Goldman, JM ;
Melo, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) :1451-1464
[9]
Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia [J].
Griesshammer, M ;
Heinze, B ;
Bangerter, M ;
Heimpel, H ;
Fliedner, TM .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (11-12) :836-838
[10]
HEIM S, 1995, CANC CYTOGENETICS CH